Long-Term Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma: A Pooled Analysis of Clinical Trials-Reference-Cited by-同舟云学术

Long-Term Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma: A Pooled Analysis of Clinical Trials

Published:2018-02 Issue:1 Volume:16 Page:6-12.e4
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Tannir Nizar M.,Figlin Robert A.,Gore Martin E.,Michaelson M. Dror,Motzer Robert J.,Porta Camillo,Rini Brian I.,Hoang Caroline,Lin Xun,Escudier Bernard

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference36 articles.

1. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2009

2. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

3. Pazopanib versus sunitinib in renal cancer;Motzer;N Engl J Med,2013

4. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2006

5. Sunitinib in patients with metastatic renal cell carcinoma;Motzer;JAMA,2006

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and metabolomic characterization of Brivanib‐Induced hypertension in metastatic colorectal cancer;Cancer Medicine;2023-06-17

2. Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase Inhibitors;European Urology Focus;2022-11

3. Molecular and Functional Analysis of Sunitinib-Resistance Induction in Human Renal Cell Carcinoma Cells;International Journal of Molecular Sciences;2021-06-16

4. Downregulation of GRK5 hampers the migration of breast cancer cells;Scientific Reports;2019-10-29

5. Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 Expression;Clinical Genitourinary Cancer;2019-06